These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37234179)

  • 21. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
    Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
    Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1476-1481. PubMed ID: 31907159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery.
    Jian FX; Bao PX; Li WF; Cui YH; Hong HG
    BMC Cancer; 2023 Mar; 23(1):269. PubMed ID: 36964570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues.
    Ghanbari S; Salimi A; Rahmani S; Nafissi N; Sharifi-Zarchi A; Mowla SJ
    PLoS One; 2021; 16(6):e0253009. PubMed ID: 34101749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
    Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
    J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA WT1-AS attenuates hypoxia/ischemia-induced neuronal injury during cerebral ischemic stroke via miR-186-5p/XIAP axis.
    You J; Qian F; Huang Y; Guo Y; Lv Y; Yang Y; Lu X; Guo T; Wang J; Gu B
    Open Med (Wars); 2022; 17(1):1338-1349. PubMed ID: 35959150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer.
    Chen C; Liu X; Chen C; Chen Q; Dong Y; Hou B
    Ann Clin Lab Sci; 2019 May; 49(3):302-308. PubMed ID: 31308028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Total Oxidant Status to the Antioxidant Capacity Ratio as a Valuable Biomarker in Breast Cancer Patients.
    Ahmadzadeh A; Khodayar MJ; Salehcheh M; Nazari Khorasgani Z; Matin M
    Rep Biochem Mol Biol; 2023 Jul; 12(2):277-283. PubMed ID: 38317813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A; Babashah S; Garshasbi M
    J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
    Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
    Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
    Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
    Wang LB; Feng L; He J; Liu B; Sun JG
    Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
    Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
    Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Omentin-1 with Oxidative Stress and Clinical Significances in Patients with Breast Cancer.
    Tahmasebpour N; Hosseinpour Feizi MA; Ziamajidi N; Pouladi N; Montazeri V; Farhadian M; Abbasalipourkabir R
    Adv Pharm Bull; 2020 Jan; 10(1):106-113. PubMed ID: 32002368
    [No Abstract]   [Full Text] [Related]  

  • 38. miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression.
    El Kilany FH; Youness RA; Assal RA; Gad MZ
    Breast Dis; 2021; 40(3):161-169. PubMed ID: 33749631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of
    Shishavan NS; Sasani ST; Salehi Z; Azhang MR
    Microrna; 2022; 11(3):263-270. PubMed ID: 36082867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
    Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.